MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Alhalabi, Omar, Chen, Jianfeng, Zhang, Yuxue, Lu, Yang, Wang, Qi, Ramachandran, Sumankalai, Tidwell, Rebecca Slack, Han, Guangchun, Yan, Xinmiao, Meng, Jieru, Wang, Ruiping, Hoang, Anh G, Wang, Wei-Lien, Song, Jian, Lopez, Lidia, Andreev-Drakhlin, Alex, Siefker-Radtke, Arlene, Zhang, Xinqiao, Benedict, William F, Shah, Amishi Y, Wang, Jennifer, Msaouel, Pavlos, Zhang, Miao, Guo, Charles C, Czerniak, Bogdan, Behrens, Carmen, Soto, Luisa, Papadimitrakopoulou, Vassiliki, Lewis, Jeff, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Lee, Jack, Roth, Jack, Swisher, Stephen, Wistuba, Ignacio, Heymach, John, Wang, Jing, Campbell, Matthew T, Efstathiou, Eleni, Titus, Mark, Logothetis, Christopher J, Ho, Thai H, Zhang, Jianjun, Wang, Linghua, Gao, Jianjun
Published in Nature communications (04.04.2022)
Published in Nature communications (04.04.2022)
Get full text
Journal Article